Omega-6/Omega-3 Fatty Acid Ratio and Tumorigenesis

描述（由申请人提供）：尽管最近的研究表明omega-6 （n-6）与omega-3 （n-3）脂肪酸的比例与癌症风险之间存在联系，但在大多数西方人中发现的高n-6/n-3比例（bbb15）是否促进肿瘤发生，或者平衡的n-6/n-3脂肪酸比例是否可以减少癌症发展的问题仍有待于在合格的实验动物模型中澄清。我的实验室最近产生了一种新的转基因小鼠模型，表达秀丽隐杆线虫的脂肪-1基因，能够将n-6脂肪酸转化为n-3脂肪酸，这在野生型小鼠中是不存在的。这些转基因动物具有丰富的n-3脂肪酸和平衡的n-6/n-3脂肪酸比例（1:1）的特点，而野生型小鼠在相同的饮食中维持高n-6和缺乏n-3脂肪酸时，该比例为bbbb30。使用这些转基因动物可以避免潜在的饮食混杂因素，并将为n-3脂肪酸和n-6/n-3比值的影响提供更可靠的证据。我们的前期实验显示野生型和fat-1转基因小鼠B16黑色素瘤的形成和生长有显著差异。这一令人兴奋的观察结果使我们假设平衡的n-6/n-3脂肪酸比例可能对癌症发展具有保护作用，并且这种抗癌作用是由某些类二十烷或脂质介质介导的癌症相关基因表达的变化引起的。具体目的是：1)研究B16黑色素瘤细胞在fat-1转基因和野生型小鼠体内的致瘤性和转移性；2)利用微阵列技术研究fat-1转基因小鼠和野生型小鼠肿瘤细胞和间质组织的基因表达谱；3)确定类二十烷酸生物合成的变化是否对基因表达和肿瘤生长的影响负责。包括微阵列和脂质组学在内的几种方法将用于鉴定相关的介质。从这些研究中获得的信息将增加我们对n-3脂肪酸以及n-6/n-3脂肪酸比例在癌症预防中的重要性的理解，并有助于指导饮食建议。

DESCRIPTION (provided by applicant): Although recent research suggests a link between the ratio of omega-6 (n-6) to omega-3 (n-3] fatty acids and cancer risk, the question as to whether a high n-6/n-3 ratio (>15), as found in most Western people, promotes tumorigenesis or if a balanced n-6/n-3 fatty acid ratio can reduce cancer development remains to be clarified in well-qualified experimental animal models. My lab has recently generated a novel transgenic mouse model that expresses the C. elegans fat-1 gene capable of converting n-6 to n-3 fatty acids, which is absent in wild type mice. These transgenic animals are characterized by an abundance of n-3 fatty acids and a balanced n-6/n-3 fatty acid ratio (1:1) in their tissues and organs, whereas wild type mice have a ratio of > 30 when maintained on the same diet high in n-6 and deficient in n-3 fatty acids. Use of these transgenic animals can avoid potential confounding factors of diet and will provide more reliable evidence on the effects of n-3 fatty acids and n-6/n-3 ratio. Our pilot experiments showed a marked difference in tumor formation and growth of B16 melanoma between wild type and fat-1 transgenic mice. This exciting observation led us to hypothesize that a balanced n-6/n-3 fatty acid ratio may have a protective effect against cancer development, and that this anticancer effect is induced by changes in cancer-related gene expression mediated by certain eicosanoids or lipid mediators. Specific aims are: 1) To determine the tumorigenicity and metastasis of B16 melanoma cells implanted in the fat-1 transgenic and wild type mice; 2) To characterize gene expression patterns of the tumor cells and stromal tissues in the fat-1 transgenic and wild type mice using a microarray technology; and 3) To determine if changes in eicosanoid biosynthesis are responsible for the effects on gene expression and tumor growth. Several approaches including microarray and lipidomics will be used to identify the involved mediators. Information derived from these studies will increase our understanding of the importance of n-3 fatty acids as well as n-6/n-3 fatty acid ratio in cancer prevention and help guide dietary advice.